Drug Database
Back to search

Switzerland· 36289015

Novesin 0,4 %, Augentropfen

A oxybuprocaine product containing oxybuprocaini hydrochloridum, registered in Switzerland by OmniVision AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC S01HA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNovesin 0,4 %, AugentropfenATCS01HA02REGISTER NO.36289015PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxybuprocaini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Oxybuprocaine is registered in 11 of 19 countries.

Countries holding a registration under ATC S01HA02 (oxybuprocaine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search oxybuprocaine products by name

Oxybuprocaine · ATC S01HA02

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
oxybuprocaini hydrochloridum
Manufacturer
OmniVision AG
Country
Switzerland (CH)
ATC code
S01HA02
ATC class
Oxybuprocaine
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for oxybuprocaine.

Graded by severity as the source publishes them — 40 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check oxybuprocaine against other medicinesHow interaction checks work

Oxybuprocaine · interactions on record

40 records

  • 40 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybuprocaine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybuprocaine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Benoxinat Zur Anästhesie In Der Oto-Rhino-Laryngologie, Novain
  • Belgium · Minims Oxybuprocaine Chlorhydrate Bausch + Lomb Ireland Limited, Minims Oxybuprocaïnehydrochloride Bausch + Lomb Ireland Limited
  • Bulgaria · Бенокси
  • Czechia · Benoxi, Oxybuprocaine Olikla
  • Germany · Conjuncain® Edo®, Novesine
  • Denmark · Oftasen, Oxybuprocainhydrochlorid Agepha
  • Estonia · Novain
  • Spain · Oxibuprocaína Hidrocloruro Agepha
  • Finland · Minims, Obupro 4 Mg/Ml Silmätipat, Liuos
  • France · Cebesine, Chlorhydrate D’oxybuprocaine Thea
  • United Kingdom (Northern Ireland) · Oxybuprocaine Hydrochloride Alfa Intes
  • Croatia · Ophtesia
  • Hungary · Humacain, Oxybuprocaine Hydrochloride Agepha
  • Ireland · Oxybuprocaine Agepha
  • Iceland · Novain
  • Italy · Benoxinato Cloridrato Intes, Novesina
  • Lithuania · Novain
  • Luxembourg · Conjuncain Edo, Minims
  • Latvia · Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml
  • Netherlands · Minims, Monofree
  • Norway · Obupro, Oxibuprokain Minims Bausch + Lomb Ireland Limited
  • Poland · Novain, 4 Mg/Ml,
  • Portugal · Anestocil, Novain 4 Mg/Ml Colírio,
  • Romania · Benoxi, Oftacain
  • Sweden · Novain, Oxibuprokain Bausch & Lomb
  • Slovakia · Benoxi, Oxybuprocaine Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/67ae48d8-aabe-4db6-87d8-9ca6c3d8f6d8
GET /v1/drugs/67ae48d8-aabe-4db6-87d8-9ca6c3d8f6d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about oxybuprocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console